These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22613518)

  • 21. Eosinophilic responses to stent implantation and the risk of Kounis hypersensitivity associated coronary syndrome.
    Kounis NG; Giannopoulos S; Tsigkas GG; Goudevenos J
    Int J Cardiol; 2012 Apr; 156(2):125-32. PubMed ID: 21700348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model.
    Tada N; Virmani R; Grant G; Bartlett L; Black A; Clavijo C; Christians U; Betts R; Savage D; Su SH; Shulze J; Kar S
    Circ Cardiovasc Interv; 2010 Apr; 3(2):174-83. PubMed ID: 20407114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cre8™ coronary stent: preclinical in vivo assessment of a new generation polymer-free DES with Amphilimus™ formulation.
    Moretti C; Lolli V; Perona G; Vignolini MC; Cabiale K; Falzone M; Galloni M
    EuroIntervention; 2012 Jan; 7(9):1087-94. PubMed ID: 22130128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a novel slow-release paclitaxel-eluting stent with a bioabsorbable polymeric surface coating.
    Jabara R; Chronos N; Conway D; Molema W; Robinson K
    JACC Cardiovasc Interv; 2008 Feb; 1(1):81-7. PubMed ID: 19393150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Promising Approach for Improving the Coating Stability and In Vivo Performance of Biodegradable Polymer-Coated Sirolimus-Eluting Stent.
    Bedair TM; Kang SN; Joung YK; Han DK
    J Biomed Nanotechnol; 2016 Nov; 12(11):2015-28. PubMed ID: 29364616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term biocompatibility evaluation of a novel polymer-coated stent in a porcine coronary stent model.
    Huang Y; Liu X; Wang L; Li S; Verbeken E; De Scheerder I
    Coron Artery Dis; 2003 Aug; 14(5):401-8. PubMed ID: 12878906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Six-month clinical outcomes of Firebird 2TM sirolimus-eluting stent implantation in real-world patients with coronary artery diseases.
    Ge JB; Zhang F; Qian JY; Ge L; Liu XB; Zhou J
    Chin Med J (Engl); 2011 Mar; 124(6):831-5. PubMed ID: 21518588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of thin-strut cobalt-chromium stents and stainless steel stents in a porcine model of neointimal hyperplasia.
    Milewski K; Zurakowski A; Pajak J; Pajak-Zielinska E; Liszka L; Buszman PP; Bis J; Debinski M; Buszman PE
    Med Sci Monit; 2010 Jan; 16(1):BR40-4. PubMed ID: 20037484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel drug-eluting stent using bioabsorbable polymer technology: two-year follow-up of the CURAMI registry.
    Tin Hay E; Hou XM; Lim J; Low A; Teo SG; Tan HC; Lee CH
    Int J Cardiol; 2009 Jan; 131(2):272-4. PubMed ID: 17942172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
    Waksman R; Pakala R
    EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histological analysis of cobalt-chromium stents with and without Camouflage® polymer coating: experimental porcine carotid artery model.
    Grudtner MA; de Lara Elesbão JL; Gutierrez PS; Meyer FS; Pereira AH
    Vascular; 2011 Apr; 19(2):89-96. PubMed ID: 21489934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
    Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC
    Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials.
    Stefanini GG; Byrne RA; Serruys PW; de Waha A; Meier B; Massberg S; Jüni P; Schömig A; Windecker S; Kastrati A
    Eur Heart J; 2012 May; 33(10):1214-22. PubMed ID: 22447805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biocompatibility of tetramethylpyrazine-eluting stents in normal porcine coronary arteries.
    Ma GS; Chen LJ; Chen Z; Ding S; Shen CX; Feng Y
    Biomed Pharmacother; 2008 Feb; 62(2):125-9. PubMed ID: 17764890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss.
    Mehilli J; Kastrati A; Wessely R; Dibra A; Hausleiter J; Jaschke B; Dirschinger J; Schömig A;
    Circulation; 2006 Jan; 113(2):273-9. PubMed ID: 16391155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of a novel nano-porous polymer-free sirolimus-eluting stent in pigs.
    Chen M; Zheng B; Wu Z; Peng HY; Wang XG; Zhang B; Huo Y
    Chin Med J (Engl); 2013; 126(24):4731-5. PubMed ID: 24342320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Periprocedural (30-day) risk of myocardial infarction after drug-eluting coronary stent implantation: a meta-analysis comparing cobalt-chromium and stainless steel drug-eluting coronary stents.
    Moreno R; Jimenez-Valero S; Sanchez-Recalde A; Galeote G; Calvo L; Martin-Reyes R; Sabate M; Plaza I; Macaya C; Lopez-Sendon JL
    EuroIntervention; 2011 Mar; 6(8):1003-10. PubMed ID: 21330250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.